TABLE 2.
Feature | CTCL (n=18) | EID (n=29) | P (Chi-2) |
---|---|---|---|
Epidermal CD8/CD3 < 10% | 10 (56%) | 6 (21%) | 0.03 |
Epidermal CD8/CD3: 10–50% | 1 (6%) | 9 (33%) | 0.086 |
Epidermal CD8/CD3 >50% | 2 (17%) | 5 (19%) | >0.9 |
CD30+ lymphocytes | 14 (78%) | 11 (38%) | 0.009 |
JunB+ lymphocytes | 3(17%) | 0 | 0.049 |
β-catenin+ lymphocytes | 5 (28%) | 9 (31%) | >0.99 |
CTCL, cutaneous T cell lymphoma; EID, erythrodermic inflammatory dermatoses